Company Venus Medtech (Hangzhou) Inc.
Equities
2500
CNE100003PJ8
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 HKD | -0.71% |
|
-.--% | -.--% |
06-14 | Venus Medtech Venusp-Valve Completes First Implantation in Ide Pivotal Clinical Study in U.S | CI |
06-14 | Venus Medtech (Hangzhou) Implants First Patient with VenusP-Valve in US Clinical Study | MT |
Business Summary
Number of employees: 865
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
VenusA Series Products
83.4
%
| 416 | 88.1 % | 453 | 83.4 % | +8.74% |
VenusP-Valve
15.6
%
| 48 | 10.1 % | 84 | 15.6 % | +77.71% |
Others
1.1
%
| 9 | 1.9 % | 6 | 1.1 % | -34.43% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
85.2
%
| 412 | 87.2 % | 463 | 85.2 % | +12.21% |
Others
14.8
%
| 60 | 12.8 % | 80 | 14.8 % | +33.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hou-Sen Lim
CEO | Chief Executive Officer | 50 | 16-11-30 |
Fei Wang
DFI | Director of Finance/CFO | 47 | 23-01-03 |
Meirong Liu
BRD | Director/Board Member | 47 | 17-10-31 |
Joyce Heo
SAM | Sales & Marketing | - | 22-03-17 |
Shakeel Osman
SAM | Sales & Marketing | - | 22-03-17 |
Wai Chiu Wong
SEC | Corporate Secretary | 69 | 21-01-17 |
Corporate Officer/Principal | 63 | 19-07-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hou-Sen Lim
CEO | Chief Executive Officer | 50 | 16-11-30 |
Ting Yuk Wu
CHM | Chairman | 69 | 18-11-25 |
Wei Wang
BRD | Director/Board Member | 41 | 18-11-25 |
Chi Wai Suen
BRD | Director/Board Member | 59 | 19-07-07 |
Ao Zhang
BRD | Director/Board Member | 39 | 23-01-29 |
Lingling Yang
BRD | Director/Board Member | 62 | 18-11-25 |
Min Shao
CHM | Chairman | 50 | 22-08-30 |
Meirong Liu
BRD | Director/Board Member | 47 | 17-10-31 |
Chen Wei
BRD | Director/Board Member | - | 11-29 |
Liqiao Ma
BRD | Director/Board Member | 39 | 12-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,208 | 0 | 0 | 73.87 % |
Stock B | 1 | 441,010,235 | 325,785,161 ( 73.87 %) | 0 |
Company contact information
Venus Medtech (Hangzhou), Inc.
40th Floor Dah Sing Financial Centre
310053, Wanchai
+
http://www.venusmedtech.com![address Venus Medtech (Hangzhou) Inc.(2500)](https://cdn.zonebourse.com/static/address/103501726.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 315M | |
+12.37% | 130B | |
-9.54% | 10.81B | |
-17.40% | 7.12B | |
+47.72% | 6.46B | |
-31.81% | 3.98B | |
+8.15% | 3.43B | |
-20.83% | 2.48B | |
-18.87% | 1.91B | |
-25.13% | 1.66B |
- Stock Market
- Equities
- 2500 Stock
- Company Venus Medtech (Hangzhou) Inc.